223 related articles for article (PubMed ID: 8249138)
1. Epstein-Barr virus--associated posttransplant lymphoproliferative disorder presenting as perirenal transplant lymphocele.
Squiers EC; West JC; Leonard D; Latsha R; Miller J; Fetterolf N; Kelley SE; Tyler W
Transplantation; 1993 Nov; 56(5):1278-9. PubMed ID: 8249138
[No Abstract] [Full Text] [Related]
2. [Post-transplantation lymphomas and Epstein-Barr virus].
Caillard S; Heibel F; Benaicha M; Moulin B
Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
[TBL] [Abstract][Full Text] [Related]
4. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face.
Cho KH; Kim CW; Lee DY; Sohn SJ; Kim DW; Chung JH
Br J Dermatol; 1996 Apr; 134(4):791-6. PubMed ID: 8733395
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
Rustgi VK
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
[No Abstract] [Full Text] [Related]
6. Epstein-Barr-virus-associated post-transplant B-cell lymphoma presenting as allograft artery stenosis.
Hestin D; Claudon M; Champigneulles J; Renoult E; Hubert J; Kessler M
Nephrol Dial Transplant; 1996 Jun; 11(6):1164-7. PubMed ID: 8671992
[No Abstract] [Full Text] [Related]
7. Duration of Epstein-Barr virus (EBV)-associated polyclonal lymphoproliferative disease (LPD) following bone marrow transplantation.
Imashuku S; Iwami H; Tsunamoto K; Hibi S; Todo S
Bone Marrow Transplant; 1996 Oct; 18(4):823-4. PubMed ID: 8899207
[No Abstract] [Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative eruption with progression to large granular lymphocytic leukaemia.
Cho KH; Kim CW; Kwon OS; Yang SG; Park KC; Park MH; Cho HI; Kim JG
Br J Dermatol; 1997 Sep; 137(3):426-30. PubMed ID: 9349343
[TBL] [Abstract][Full Text] [Related]
9. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
10. Overview of posttransplant B-cell lymphoproliferative disorders.
Swinnen LJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
[TBL] [Abstract][Full Text] [Related]
11. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
Hidalgo M; Lumbreras C; Aguado JM
Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
[No Abstract] [Full Text] [Related]
12. Epstein-Barr virus-associated lymphoproliferative disorder. Applications of immunoperoxidase and molecular biologic techniques.
Kornstein MJ; Weber J; Luck JB; Massey GV; Strom S; McWilliams NB
Arch Pathol Lab Med; 1989 May; 113(5):481-4. PubMed ID: 2540726
[TBL] [Abstract][Full Text] [Related]
13. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
Lager DJ; Slagel DD; Burgart LJ
Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus. A serial killer or an innocent bystander?
Sangüeza OP
Arch Dermatol; 1997 Sep; 133(9):1156-7. PubMed ID: 9301594
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
[No Abstract] [Full Text] [Related]
16. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder?
Cockfield SM; Preiksaitis J; Harvey E; Jones C; Hebert D; Keown P; Halloran PF
Transplant Proc; 1991 Feb; 23(1 Pt 2):1106-7. PubMed ID: 1846454
[No Abstract] [Full Text] [Related]
17. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort.
Baiocchi OC; Colleoni GW; Caballero OL; Vettore AL; Andrade AL; Pestana JO
Haematologica; 2004 Mar; 89(3):366-8. PubMed ID: 15020282
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis.
Imashuku S; Naya M; Yamori M; Nakabayashi Y; Hojo M; Kihara A; Tabata Y; Akioka C; Hibi S; Todo S
Bone Marrow Transplant; 1997 May; 19(10):1059-60. PubMed ID: 9169655
[No Abstract] [Full Text] [Related]
19. Interleukin-10 and Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.
Birkeland SA; Bendtzen K
Transplantation; 1996 May; 61(9):1425-6. PubMed ID: 8629314
[No Abstract] [Full Text] [Related]
20. Fatal case of Epstein-Barr virus-induced lymphoproliferative disorder associated with a human immunodeficiency virus infection.
Beissner RS; Rappaport ES; Diaz JA
Arch Pathol Lab Med; 1987 Mar; 111(3):250-3. PubMed ID: 3030225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
